In this Panel Discussion we assemble experts from across the spectrum of cancer research to explain how they use these techniques in their research, provide key tips for best practice when using them ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, ...
The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of ...
Schematic representation of S2-binding antibodies to the SARS-CoV-2 spike protein. The greatest difficulty for vaccine and drug design three years into the Covid-19 pandemic is the proliferation of ...
Monoclonal antibodies (mAbs) are one of the most successful therapeutic drug classes, generating lucrative sales for the pharmaceutical industry. In 2016, more than 20 therapeutic antibodies gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results